![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Drug Research
Schreiner MediPharm Equips Cap-Lock Security Label with RFID Technology
Schreiner MediPharm, a Germany-based global provider of innovative functional label solutions for the healthcare industry, has enhanced its tamper-evident specialty label, Cap-Lock, with a...
Drug Research
3P Biopharmaceuticals and SpyBiotech enter into a vaccine contract manufacturing agreement
3P Biopharmaceuticals, a leading Contract Development and Manufacturing Organization (CDMO) specialized in process development and cGMP manufacturing of biologics, has signed a manufacturing agreement...
Drug Research
RedHill Biopharma secures expanded manufacturing for COVID-19 therapeutic candidate
RedHill Biopharma, a specialty biopharmaceutical company, has announced collaborations with two specialist pharmaceutical manufacturers in Europe and Canada to ramp-up manufacturing of opaganib, currently...
Drug Research
BioIVT Launches HEPATOMUNE Kit to Facilitate Liver Toxicity and Inflammation Studies for Drug Discovery and Disease Research
BioIVT, a leading provider of research models and services for drug and diagnostic development, launched its HEPATOMUNE® kit, a long-term, stable, in vitro model...
Drug Research
Samsung Biologics inks development partnership with Dinona for potential COVID-19 treatment
Samsung Biologics (207940.KS) has entered into a partnership agreement with biotech Dinona, further expanding its CDO capabilities to provide a full scope of its...
Drug Research
FUJIFILM Diosynth Biotechnologies Stands Ready to Manufacture Lilly COVID-19 Antibody for Low- and Middle-Income Countries
FUJIFILM Diosynth Biotechnologies, a world leading Contract Development and Manufacturing Organization (CDMO) for biologics, viral vaccines and viral vectors, announced that it will manufacture...
Drug Research
Mapi Pharma Announces Commissioning of a Vaccine Production Facility to Support the Supply of COVID-19 Vaccines to Israel and EU Countries
Mapi Pharma Ltd., a fully integrated, late clinical stage biopharmaceutical company, announced that it will dedicate capacity at its manufacturing facility to support the...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read